|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Breast Neoplasms | |||||
| Fever | |||||
| Hematologic Diseases | |||||
| Neutropenia | |||||
| Sepsis | |||||
| 2 | More general conditions related to this trial | ||||
| Agranulocytosis | |||||
| Breast Diseases | |||||
| Leukocyte Disorders | |||||
| Leukopenia | |||||
| Neoplasms | |||||
| Neoplasms by Site | |||||
| Skin Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| FLAC chemotherapy with GM-CSF | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Fluorouracil | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antimetabolites | |||||
| Antimetabolites, Antineoplastic | |||||
| Antineoplastic Agents | |||||
| Immunologic Factors | |||||
| Immunosuppressive Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| National Cancer Institute (NCI) | |||||